InvestorsHub Logo
Followers 31
Posts 6515
Boards Moderated 0
Alias Born 01/20/2016

Re: None

Wednesday, 03/07/2018 8:30:47 AM

Wednesday, March 07, 2018 8:30:47 AM

Post# of 466127
More confirming news--from today's PR---yes--our drug works !!!--- these data suggest that sigma-1 receptor activation with ANAVEX®2-73 could be a common target with widespread pharmacological benefit, including those disorders that elicit seizures, regardless of differences in the underlying CNS pathophysiology.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News